Cargando…

Time above range for predicting the development of type 2 diabetes

AIM: To investigate the prognostic value of time range metrics, as measured by continuous glucose monitoring, with respect to the development of type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: A total of 499 persons without diabetes from the general population were followed-up for 5 years. Time...

Descripción completa

Detalles Bibliográficos
Autores principales: Marco, Alejandra, Pazos-Couselo, Marcos, Moreno-Fernandez, Jesús, Díez-Fernández, Ana, Alonso-Sampedro, Manuela, Fernández-Merino, Carmen, Gonzalez-Quintela, Arturo, Gude, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772988/
https://www.ncbi.nlm.nih.gov/pubmed/36568777
http://dx.doi.org/10.3389/fpubh.2022.1005513
Descripción
Sumario:AIM: To investigate the prognostic value of time range metrics, as measured by continuous glucose monitoring, with respect to the development of type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: A total of 499 persons without diabetes from the general population were followed-up for 5 years. Time range metrics were measured at the start and medical records were checked over the period study. RESULTS: Twenty-two subjects (8.3 per 1,000 person-years) developed T2D. After adjusting for age, gender, family history of diabetes, body mass index and glycated hemoglobin concentration, multivariate analysis revealed 'time above range' (TAR, i.e., with a plasma glucose concentration of >140 mg/dL) to be significantly associated with a greater risk (OR = 1.06, CI 1.01–1.11) of developing diabetes (AUC = 0.94, Brier = 0.035). CONCLUSIONS: Time above range provides additional information to that offered by glycated hemoglobin to identify patients at a higher risk of developing type 2 diabetes in a population-based study.